Loading data
ENLVNasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Research and development expense | 9.2 m USD | 10.62 m USD | 19.01 m USD | 18.69 m USD | 12.88 m USD |
| Operating profit | -15.03 m USD | -15.89 m USD | -29.4 m USD | -25.8 m USD | -19.29 m USD |
| Profit before tax | 1.62 bn USD | -15.01 m USD | -29.07 m USD | — | — |
| Income tax expense | 382.65 m USD | — | — | — | — |
| Net income (reported basis) | 1.24 bn USD | -15.01 m USD | -29.07 m USD | -31.06 m USD | -14.47 m USD |
| Net income attributable to common shareholders | — | — | — | 31.06 m USD | 14.47 m USD |
| Basic earnings per share | 27.04 USD/share | -0.73 USD/share | -1.56 USD/share | -1.69 USD/share | -0.81 USD/share |
| Diluted earnings per share | 25.48 USD/share | -0.73 USD/share | -1.56 USD/share | -1.69 USD/share | -0.81 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.